Development and validation of a multiparametric MRI-based radiomics nomogram for the tripartite discrimination of primary benign, primary malignant, and metastatic lumbar spinal tumors - Top-Institutions - MDSpire

Development and validation of a multiparametric MRI-based radiomics nomogram for the tripartite discrimination of primary benign, primary malignant, and metastatic lumbar spinal tumors

  • By

  • Canghai Shen

  • Shuai Yang

  • Xi Chen

  • Yongjian Feng

  • Yancheng Song

  • Jianxi Zhou

  • Yunchuan Sun

  • June 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Harvard University (Massachusetts General Hospital and Brigham and Women’s Hospital)
    Harvard University (Massachusetts General Hospital and Brigham and Women’s Hospital)

    Boston, Massachusetts

    Key Differentiators

    • Radiology
    • Nuclear Medicine
    • Medical Imaging

  • #2

    Peking University Cancer Hospital & Institute
    Peking University Cancer Hospital & Institute

    Beijing, China

    Key Differentiators

    • Oncology
    • Radiology

  • #3

    University Hospital Cologne
    University Hospital Cologne

    Cologne, Germany

    Key Differentiators

    • Radiology
    • Oncology

  • #4

    University Hospital Regensburg
    University Hospital Regensburg

    Regensburg, Germany

    Key Differentiators

    • Radiology
    • Oncology

  • #5

    First Affiliated Hospital of Sun Yat-sen University
    First Affiliated Hospital of Sun Yat-sen University

    Guangzhou, China

    Key Differentiators

    • Oncology
    • Radiology

Original Source(s)

Development and validation of a multiparametric MRI-based radiomics nomogram for the tripartite discrimination of primary benign, primary malignant, and metastatic lumbar spinal tumors

  • by Canghai Shen, Shuai Yang, Xi Chen, Yongjian Feng, Yancheng Song, Jianxi Zhou, Yunchuan Sun

  • June 10, 2026

Related Content

Multidisciplinary team care and outcomes in FNCLCC grade 3 soft tissue sarcoma: a propensity score–matched and weighted cohort study

Survival benefit of extended lymphadenectomy in endometrial cancer: a meta-analysis with risk-stratified subgroup analysis

POC1A promotes malignant phenotypes in non-triple-negative breast cancer cell models with EMT- and Wnt/β-catenin-related alterations